HIV News and Research

RSS

EPO provides notice of intent to issue European Patent Application for Aethlon Hemopurifier

Aethlon Medical, Inc., the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the European Patent Office (EPO) has provided the Company a notice of intent to issue European Patent Application No. 04 703 672.8 entitled "Method For Removal of Viruses From Blood By Lectin Affinity Hemodialysis."

7 Nov 2012

AIDS organizations release discussion paper on post-2015 development agenda

The International AIDS Alliance, in collaboration with the Stop AIDS Alliance and STOP AIDS NOW!, has published "a discussion paper to help the HIV community to engage in" discussions surrounding the post-2015 development agenda, the International AIDS Alliance's blog reports.

6 Nov 2012

Blog reports on meeting of world's largest HIV vaccine research network

KPLU 88.5's "Humanosphere" blog reports on a meeting of the HIV Vaccine Trials Network (HVTN), "the world's largest HIV vaccine research network," held in Seattle this week. "We actually don't know what the agenda is," HVTN Executive Director Jim Kublin said during a lecture, titled "Scientific Agenda, the Next Seven Years," according to the blog.

3 Nov 2012

'Details of implementation' critical to reaching goal of AIDS-free generation

Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."

3 Nov 2012

'Keep the Promise on HIV/AIDS' March and Rally to be held on Nov. 3 in Centennial Park

Hundreds of advocates and community leaders are expected to participate in the "Keep the Promise on HIV/AIDS" March and Rally this Saturday, November 3, 2012 beginning at 1:00 pm in Centennial Park.

3 Nov 2012

Weill Cornell researchers awarded Grand Challenges Explorations grants

Weill Cornell Medical College announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

3 Nov 2012

Intensified antibiotic treatment can improve prognosis of patients with TB meningitis

Researchers from the Radboud UMC have conducted the first study globally to show that intensified antibiotic treatment can improve the prognosis of patients with tuberculous (TB) meningitis, the most severe form of TB which carries a mortality of up to 50%.

3 Nov 2012

Resolve to fight TB must be strengthened in U.S. global AIDS blueprint

As part of its "Blueprint" series discussing the creation of a U.S. global AIDS blueprint called for by Secretary of State Hillary Clinton in July, the Center for Global Health Policy's "Science Speaks" blog features an opinion piece by Salmaan Keshavjee of Harvard Medical School and Partners In Health. With an estimated 1,000 people with HIV dying of tuberculosis (TB) every day, "it is clear that our current approaches to addressing the global tuberculosis pandemic are inadequate," he writes.

3 Nov 2012

Mobile technology can help people in less-developed countries manage hypertension

Hypertension is one of the greatest epidemics threatening the health of people in low and middle-income countries. For patients struggling with high blood pressure in countries with limited access to health care, the key to improving health may be as simple as a phone call.

1 Nov 2012

Study shows reduced risk of liver-related mortality in African American women with HIV/HCV

A new study shows that African American women coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are less likely to die from liver disease than Caucasian or Hispanic women. Findings in the November issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, indicate that lower liver-related mortality in African American women was independent of other causes of death.

1 Nov 2012

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.

1 Nov 2012

New track-and-trace proposal advanced to combat drug counterfeiting, gray market

The bipartisan track and trace draft legislation released last week would allow drugs to be authenticated throughout the supply chain, which could help combat counterfeiting as well as the so-called gray market that's been highlighted in the drug shortage crisis, Democratic staffers who worked on the draft said.

1 Nov 2012

Experimental HIV test might help improve diagnosis, treatment in developing countries

"Scientists have come up with a test for the virus that causes AIDS that is 10 times more sensitive and a fraction of the cost of existing methods, offering the promise of better diagnosis and treatment in the developing world," Reuters reports.

1 Nov 2012

African American women coinfected with HIV and HCV less likely to die from liver disease than Caucasian or Hispanic women

31 Oct 2012

RUB-medical researchers receive $2.3M Gates Foundation grant for HIV vaccine research

To support their research for a vaccine against the HI-Virus, Prof. Dr. Klaus Überla of the Faculty for Medicine at the Ruhr-Universität Bochum and his research team will receive $2.3 million in funding within the next three years from the Bill & Melinda Gates Foundation. The scientists are part of the Collaboration for AIDS Vaccine Discovery (CAVD), which seeks to speed up the development of an HIV-vaccine through a rigorous exchange of information, methods and reagents.

29 Oct 2012

Blog examines PEPFAR restrictions regarding family planning

"Though the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has been touted as one of our nation's most successful initiatives in global health (and certainly one of President George W. Bush's most positive legacies) it continues to miss the mark" when it comes to family planning, global gender specialist and freelance writer Jessica Mack writes in KPLU 88.5's "Humanosphere" blog.

29 Oct 2012

Examining human rights program integration into national HIV plans

The International HIV/AIDS Alliance has been providing technical support for UNAIDS since 2011 to assist policymakers in integrating human rights programs into National Strategic Plans for HIV, the organization's blog states and notes, "As part of the project, three regional workshops were held for: East and Southern Africa; the Middle East and North Africa; and the Asia/Pacific regions."

29 Oct 2012

Improving global maternal mortality, women's health and related U.S. foreign policy

In the Center for Strategic & International Studies' "Smart Global Health" blog, Phillip Nieburg, senior associate of the CSIS Global Health Policy Center, discusses a recent report he wrote, titled "Improving Maternal Mortality and Other Aspects of Women's Health: The United States' Global Role," "that addresses key challenges to improving maternal mortality and women's health worldwide and talks about what the related priorities of U.S. foreign policy should be."

29 Oct 2012

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet.

29 Oct 2012

Scientists develop new prototype ultra sensitive disease sensor

Scientists have developed a prototype ultra-sensitive sensor that would enable doctors to detect the early stages of diseases and viruses with the naked eye, according to research published today in the journal Nature Nanotechnology.

29 Oct 2012

HIV News and Research

EPO provides notice of intent to issue European Patent Application for Aethlon Hemopurifier

AIDS organizations release discussion paper on post-2015 development agenda

Blog reports on meeting of world's largest HIV vaccine research network

'Details of implementation' critical to reaching goal of AIDS-free generation

'Keep the Promise on HIV/AIDS' March and Rally to be held on Nov. 3 in Centennial Park

Weill Cornell researchers awarded Grand Challenges Explorations grants

Intensified antibiotic treatment can improve prognosis of patients with TB meningitis

Resolve to fight TB must be strengthened in U.S. global AIDS blueprint

Mobile technology can help people in less-developed countries manage hypertension

Study shows reduced risk of liver-related mortality in African American women with HIV/HCV

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

New track-and-trace proposal advanced to combat drug counterfeiting, gray market

Experimental HIV test might help improve diagnosis, treatment in developing countries

African American women coinfected with HIV and HCV less likely to die from liver disease than Caucasian or Hispanic women

RUB-medical researchers receive $2.3M Gates Foundation grant for HIV vaccine research

Blog examines PEPFAR restrictions regarding family planning

Examining human rights program integration into national HIV plans

Improving global maternal mortality, women's health and related U.S. foreign policy

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Scientists develop new prototype ultra sensitive disease sensor

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News